FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to compositions and methods for treatment and prophylaxis of such diseases and states as transplant resorption, surgery commissures, intestine inflammatory diseases, nasal polyps and involves delivery of anti-microtubular agent to the inflammation point and this agent represents paclitaxel or its analogue, or its derivative. Invention provides the indicated treatment and prophylaxis due to destroy in microtubules function by depolymerization or stabilization of their formation that stops pathogenesis of indicated diseases.
EFFECT: valuable medicinal properties of composition, improved treatment and prophylaxis.
46 cl, 14 tbl, 81 dwg, 43 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS INHIBITING THE DEVELOPMENT OF BLOOD VESSELS AND METHOD FOR THEIR APPLICATIONS | 2001 |
|
RU2304433C2 |
| STAND FOR EXPANSION OF APERTURE INSIDE THE CANAL BODY | 1994 |
|
RU2180844C2 |
| TAXANES COVALENTLY BONDED WITH HYALURONIC ACID OR HYALURONIC ACID DERIVATIVES | 2003 |
|
RU2384593C2 |
| DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
| DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF ACTIVE SUBSTANCES | 2009 |
|
RU2513153C2 |
| POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS | 2006 |
|
RU2472812C2 |
| PROTEIN, PHARMACEUTICAL COMPOSITION, DRUG, DEVICE, KIT | 2019 |
|
RU2815577C2 |
| COMPOSITIONS AND METHODS FOR DRUG DELIVERY | 2009 |
|
RU2496482C2 |
| IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS FOR USING THEM | 2016 |
|
RU2739033C2 |
| RAPAMICIN-RELEASING STENT | 2010 |
|
RU2563429C2 |
